Clinical Trial Results:
Ranibizumab combined with selective peripheral laser photocoagulation for treatment of central retinal vein occlusion
A randomized, controlled interventional phase 2b (proof of concept) study of of the efficacy, safety, and tolerability of repeated intravitreal administration of ranibizumab combined with selective laser photocoagulation of non-perfused retinal areas in subjects with macular edema secondary to central retinal vein occlusion (CRVO)
Summary
|
|
EudraCT number |
2010-020441-27 |
Trial protocol |
DE |
Global completion date |
18 Sep 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Oct 2019
|
First version publication date |
13 Oct 2019
|
Other versions |
|
Summary report(s) |
Synopsis of the Clinical Trial Report CoRaLa |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.